Pharmaniaga completes private placement and rights issue; on track to exit PN17 by 1Q26

Pharmaniaga Bhd managing director Zulkifli Jafar. — AZLINA ABDULLAH/The Star

PETALING JAYA: Pharmaniaga Bhd has completed a rights issue and a regularisation plan, allowing the company to remain on track to exit its PN17 status by the first quarter of 2026.

In a statement, the company said a total of 3.46 billion renounceable rights shares were fully subscribed, with an oversubscription rate of 26.14%, reflecting strong support and confidence from existing shareholders.